SENS - Senseonics Holdings Inc


0.7552
-0.017   -2.198%

Share volume: 1,979,504
Last Updated: 04-25-2025
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$0.77
-0.02
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
43%
Profitability 43%
Dept financing 25%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
2.46%
1 Month
11.80%
3 Months
-31.96%
6 Months
119.03%
1 Year
73.21%
2 Year
26.90%
Key data
Stock price
$0.76
P/E Ratio 
0.00
DAY RANGE
$0.73 - $0.76
EPS 
-$0.44
52 WEEK RANGE
$0.25 - $1.40
52 WEEK CHANGE
$73.21
MARKET CAP 
310.181 M
YIELD 
N/A
SHARES OUTSTANDING 
535.574 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
1.65
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,062,033
AVERAGE 30 VOLUME 
$3,359,883
Company detail
CEO: Timothy T. Goodnow
Region: US
Website: senseonics.com
Employees: 90
IPO year: 2016
Issue type: Common Stock
Market: NYSE American
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing

Senseonics Holdings, Inc. develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. Senseonics is headquartered in Germantown, Maryland, and serves healthcare providers and patients through a network of distributors.

Recent news
loading